Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 425 of 1294 entries
View as:

Basal Bolus of Insulin Aspart Including Insulin NPH and Biphasic Insulin Aspart in Type 2 Diabetes

Phase: N/A Priority: Normal
NCT ID: NCT00600626 Org: User:
Start: 01/31/04 End: 07/31/04 Due: 07/31/05

Investigation of Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of Multiple Doses of Somapacitan in Subjects With Various Degrees of Impaired Renal Function Compared to Subjects With Normal Renal Function

Phase: N/A Priority: Normal
NCT ID: NCT03186495 Org: User:
Start: 06/20/17 End: 05/17/18 Due: 05/17/19

A Clinical Trial Investigating the Comparison of Three Different Concentrations of NN9535 in Healthy Male Subjects

Phase: N/A Priority: Normal
NCT ID: NCT00813020 Org: User:
Start: 01/31/09 End: 04/30/09 Due: 04/30/10

A Research Study Looking at How Oral Semaglutide Works in People With Type 2 Diabetes in Japan, as Part of Local Clinical Practice

Phase: N/A Priority: Normal
NCT ID: NCT04878393 Org: User:
Start: 04/30/21 End: 02/09/23 Due: 02/09/24

Examination of the Effects of Liraglutide on the Mode of Action of Insulin Detemir

Phase: N/A Priority: Normal
NCT ID: NCT00873223 Org: User:
Start: 03/31/09 End: 09/30/09 Due: 09/30/10

Observational Study of Type 1 and Type 2 Diabetes Patients Having Switched From Human Premixes to NovoMix®30

Phase: N/A Priority: Normal
NCT ID: NCT00675493 Org: User:
Start: 05/31/08 End: 01/31/09 Due: 01/31/10

Observational Study Describing Conditions for Administering Slow-acting Insulin Analogue With Oral Antidiabetic Agents in Type 2 Diabetes on Blood Glucose Control

Phase: N/A Priority: Normal
NCT ID: NCT00700960 Org: User:
Start: 06/30/07 End: 11/30/08 Due: 11/30/09

Epidemiological Assessment of the Risk for Pancreatic Cancer Associated With the Use of Semaglutide in Patients With Type 2 Diabetes - A Cohort Study Based on Nordic Registry Data

Phase: N/A Priority: Normal
NCT ID: NCT04572165 Org: User:
Start: 01/26/21 End: 12/31/24 Due: 12/31/25

A Research Study Looking at How Faster Aspart Injected in Double Concentration Works in the Body of People With Type 1 Diabetes Mellitus

Phase: N/A Priority: Normal
NCT ID: NCT03723759 Org: User:
Start: 10/26/18 End: 03/27/19 Due: 03/27/20

A Trial Investigating the Efficacy and Safety of Insulin Degludec in Children and Adolescents With Type 1 Diabetes Mellitus

Phase: N/A Priority: Normal
NCT ID: NCT01513473 Org: User:
Start: 01/16/12 End: 07/30/13 Due: 07/30/14

Research Study Looking at How Well Semaglutide Works in People Suffering From Obesity and Knee Osteoarthritis

Phase: N/A Priority: Normal
NCT ID: NCT05064735 Org: User:
Start: 10/01/21 End: 09/08/23 Due: 09/08/24

A Trial Investigating the Effect of Acute Hypoglycaemia on Cognitive Function and Brain Activation Patterns in Subjects With Type 1 Diabetes

Phase: N/A Priority: Normal
NCT ID: NCT01789593 Org: User:
Start: 01/14/13 End: 12/01/13 Due: 12/01/14

A Trial to Assess the Pharmacokinetics, Safety and Tolerability of Semaglutide in Healthy Chinese Subjects

Phase: N/A Priority: Normal
NCT ID: NCT03288740 Org: User:
Start: 09/21/17 End: 08/07/18 Due: 08/07/19

Safety and Efficacy of Liraglutide in Combination With an OAD in Subjects With Type 2 Diabetes Insufficiently Controlled on OAD Alone

Phase: N/A Priority: Normal
NCT ID: NCT01512108 Org: User:
Start: 01/10/12 End: 04/26/13 Due: 04/26/14

Trial to Compare NNC0123-0000-0338 in a Tablet Formulation and Insulin Glargine in Subjects With Type 2 Diabetes Currently Treated With Oral Antidiabetic Therapy

Phase: N/A Priority: Normal
NCT ID: NCT02470039 Org: User:
Start: 06/01/15 End: 12/31/15 Due: 12/31/16

A Pilot Study to Determine the Impact of Clopidogrel (Plavix®) on Bleeding Associated With Punch Biopsies in Healthy Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT01603342 Org: User:
Start: 12/31/07 End: 01/31/08 Due: 01/31/09

Comparing the Efficacy and Safety of NN1250 Once Daily When Titrated Using 2 Different Algorithms in Insulin naïve Subjects With Type 2 Diabetes Mellitus

Phase: N/A Priority: Normal
NCT ID: NCT01326026 Org: User:
Start: 03/31/11 End: 12/31/11 Due: 12/31/12

A Research Study to See if Kidney Damage in People With Chronic Kidney Disease and Type 2 Diabetes Living With Overweight or Obesity Can be Reduced by CagriSema Compared to Semaglutide, Cagrilintide and Placebo

Phase: N/A Priority: Normal
NCT ID: NCT06131372 Org: User:
Start: 04/01/24 End: 11/06/25 Due: 11/06/26

A Study to See How Safe a New Medicine (NNC0705-0001) is in Healthy People

Phase: N/A Priority: Normal
NCT ID: NCT07029568 Org: User:
Start: 06/13/25 End: 07/22/26 Due: 07/22/27

Efficacy and Safety of Three Times a Day BIAsp-70 Compared to Two Times a Day BIAsp-30 in Subjects With Type 2 Diabetes

Phase: N/A Priority: Normal
NCT ID: NCT00318786 Org: User:
Start: 04/30/06 End: 06/30/07 Due: 06/30/08

Use of Activated Recombinant Human Factor VII in Cardiac Surgery

Phase: N/A Priority: Normal
NCT ID: NCT00154427 Org: User:
Start: 08/31/04 End: 11/30/07 Due: 11/30/08

Safety and Efficacy of NNC-0156-0000-0009 in Haemophilia B Patients

Phase: N/A Priority: Normal
NCT ID: NCT01333111 Org: User:
Start: 04/27/11 End: 03/31/13 Due: 03/31/14

A Research Study of How Faster-acting Insulin Aspart Moves Into, Through, and Out of the Body and How it Works in the Body When Given Through an Insulin Pump to People With Type 1 Diabetes

Phase: N/A Priority: Normal
NCT ID: NCT03215498 Org: User:
Start: 07/03/17 End: 11/20/17 Due: 11/20/18

Observational Study Describing Conditions for Intensification of Insulin Therapy in Type 2 Diabetes

Phase: N/A Priority: Normal
NCT ID: NCT00712478 Org: User:
Start: 09/30/07 End: 03/31/09 Due: 03/31/10

A Study Investigating the Distribution and Metabolism of Three 14C-labeled Radioactive Study Compounds

Phase: N/A Priority: Normal
NCT ID: NCT04676906 Org: User:
Start: 11/26/20 End: 04/28/21 Due: 04/28/22